Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
37 CFR 1.825 Amendment to add or replace a “Sequence Listing” and CRF copy thereof.
37 CFR 1.825 Amendment to add or replace a “Sequence Listing” and CRF copy thereof., “Amendment to add or replace a “Sequence Listing” and CRF copy thereof”, is a CFR section of 37 CFR Part 1, Subpart G, Subject Group: Application Disclosures Containing Nucleotide and/or Amino Acid Sequences—Application Disclosures Containing Nucleotide and/or Amino Acid Sequences; in force.
https://ontology.bommaritollc.com/id/01a0f0a7-96d2-7265-ab9d-e39e2cf496cd
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 37 CFR 1.825 |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Amendment to add or replace a “Sequence Listing” and CRF copy thereofen |
| schema:url | |
| skos:prefLabel | 37 CFR 1.825 Amendment to add or replace a “Sequence Listing” and CRF copy thereof.en |
Related
Cited by (5)eli:cites
- 37 CFR 1.121 Manner of making amendments in applications.
- 37 CFR 1.173 Reissue specification, drawings, and amendments.
- 37 CFR 1.52 Language, paper, writing, margins, read-only optical disc specifications.
- 37 CFR 1.530 Statement by patent owner in ex parte reexamination; amendment by patent owner in ex parte or inter partes reexamination; inventorship change in ex parte or inter partes reexamination.
- 37 CFR 1.821 Nucleotide and/or amino acid sequence disclosures in patent applications.